It was also reported that DCN-2 was involved in different types of cancer progression and metastasis; expression of dermcidin gene was involved in the development of micro-environment of prostate cancer in hypoxia [55] and consequently it was also demonstrated before that the protein was responsible for the aggregation of platelets and inhibition of the effect of aspirin in AMI patients [21]. This evidence concerns the gene DCD and prostate carcinoma.